Evidence map›Paper›PMID 33114698›Full record

ReviewInternational journal of molecular sciences2020

The Basal Pharmacology of Palmitoylethanolamide.

Linda Rankin, Christopher J Fowler

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 3 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 3 syntheses or guidelines pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Palmitoylethanolamide in Human and Animal Obesity.Molecules (Basel, Switzerland) · 2026
    Review
  10. Review
  11. Article
  12. Review
  13. Chemical Probes for Investigating the Endocannabinoid System.Current topics in behavioral neurosciences · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Chronic palmitoylethanolamide administrationFrontiers in cellular neuroscience · 2025
    Article
  19. Article
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Linda RankinDepartment of Integrative Medical Biology, Umeå University, SE-901 87 Umeå, Sweden.
Christopher J FowlerDepartment of Integrative Medical Biology, Umeå University, SE-901 87 Umeå, Sweden.ORCID 0000-0002-6658-7874
Umeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Palmitoylethanolamide (PEA,

Indexed as

AmidesAnalgesicsAnti-Inflammatory Agents, Non-SteroidalBiological AvailabilityEthanolaminesGene Expression RegulationHumansPalmitic AcidsPPAR alphaReceptors, CannabinoidTissue DistributionAmidesAnalgesicsAnti-Inflammatory Agents, Non-SteroidalEthanolaminesGPR55 protein, humanpalmidrolPalmitic AcidsPPAR alphaPPARA protein, humanReceptors, Cannabinoidatopic eczemafatty acid amide hydrolaselow back pain–sciaticaN-acylethanolamine acid amidasepalmitoylethanolamideperoxisome proliferator-activated receptor-α

Identifiers

PMID33114698
PMCPMC7662788
OpenAlexW3097943335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.